Latest News and Press Releases
Want to stay updated on the latest news?
-
FORT COLLINS, Colo., April 14, 2020 (GLOBE NEWSWIRE) -- Geocann is proud to announce that the peer-reviewed journal, Molecules, has published the results of a double-blind, cross-over study...
-
FORT COLLINS, Colo., Aug. 23, 2019 (GLOBE NEWSWIRE) -- Geocann is proud to announce that the company has successfully commercialized the first cannabigerol (CBG) soft gel products that utilize the...
-
FORT COLLINS, Colo., July 25, 2019 (GLOBE NEWSWIRE) -- Geocann has appointed the first members of its Medical and Scientific Advisory Board. They will play an integral role in clinical study design,...
-
FORT COLLINS, Colo., July 23, 2019 (GLOBE NEWSWIRE) -- Geocann is proud to announce that the company has successfully commercialized a portfolio of food and beverage cannabis formulations that...
-
FORT COLLINS, Colo., May 29, 2019 (GLOBE NEWSWIRE) -- Geocann and Atrium Innovations are proud to announce the successful launch of cannabidiol (CBD) soft gel formulations utilizing the patented...
-
FORT COLLINS, Colo., May 14, 2019 (GLOBE NEWSWIRE) -- Geocann is proud to announce that Anthony Petraglia, M.D., has joined the company’s executive management team as Chief Medical Officer where he...
-
FORT COLLINS, Colo., May 09, 2019 (GLOBE NEWSWIRE) -- Geocann continues to set new industry standards in cannabinoid product safety and efficacy through its two-year stability data of hemp oil...
-
Geocann Launches Cannabidiol (CBD) Soft Gel Formulations Utilizing Patented Drug Delivery Technology
FORT COLLINS, Colo., May 06, 2019 (GLOBE NEWSWIRE) -- Geocann is proud to announce that the company has successfully commercialized the first formulation in a robust portfolio of CBD soft gel...
-
Geocann Introduces Patent-Protected VESIsorb® Formulated Cannabis Products to the Global Marketplace
FORT COLLINS, Colo., April 19, 2019 (GLOBE NEWSWIRE) -- Geocann is proud to announce that the company has successfully leveraged a robust intellectual property portfolio by applying patented drug...